Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 2012

View Archived Issues

Bayer presents promising results from phase III studies of riociguat

Enlivex's lead product protects against GVHD in bone marrow transplantation

SP-333 demonstrates efficacy as treatment for gastrointestinal diseases

Bayer Schering Pharma prepares new agents for cancer

French group discloses novel agents for bone cancer

Novel potassium channel blockers presented by Xention

Swiss and German scientists synthesize new S1P receptor agonists

SJT Molecular Research divulges new agents for metabolic syndrome

Ares Trading discloses novel chemokine receptor ligands

Fujifilm Kyowa Kirin Biologics plans to develop bevacizumab biosimilar

SymBio completes recruitment in Japanese phase II study of antiemetic patch

COLTHERES consortium reports novel approaches to colon cancer therapy

Sosei confirms MAA filing of COPD treatment

New IL-1 receptor antagonist may ameliorate intestinal inflammation

Eisai signs agreement with Brazilian health agency for malaria and neglected tropical diseases

DepoVax found to enhance effect of investigational cocaine vaccine

Ezose enters collaboration to discover diagnostic biomarkers for multiple sclerosis

Qiagen and Bayer to collaborate on companion diagnostics for targeted anticancer therapies

Durata Therapeutics achieves milestone in phase III DISCOVER 2 trial

Prodrug formulated to deliver simvastatin to skeletal tissue

Biotecnol and PolyTherics to develop Tribody antibody drug conjugates

ZIOPHARM Oncology advances Ad-RTS-IL-12 to phase II

United Therapeutics receives complete response letter for oral treprostinil

FDA accepts NDA filing for controlled-release misoprostol vaginal insert

Biken and Mitsubishi Tanabe set to launch Tetrabik in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...